Dr. Eghtedar's primary field of interest is novel treatments for myeloid malignancies along with alternative donor transplants for patients without a fully matched donor. During his fellowship in Karmanos Cancer Institute transplant program, he investigated different aspects of improving immune suppression to better combat graft-versus-host disease in both acute and chronic settings
View More
